Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathways

Fei Wang,Chong Yuan,Bo Liu,Yan-Fang Yang,He-Zhen Wu
DOI: https://doi.org/10.1186/s12967-022-03504-6
IF: 8.44
2022-07-07
Journal of Translational Medicine
Abstract:Breast cancer (BC) is one of the most common malignant tumors with the highest mortality in the world. Modern pharmacological studies have shown that Syringin has an inhibitory effect on many tumors, but its anti-BC efficacy and mechanism are still unclear.
medicine, research & experimental
What problem does this paper attempt to address?